STRIDE INC (LRN) Stock Analyst Ratings
NYSE:LRN - New York Stock Exchange, Inc. - US86333M1080 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to LRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 116.54. This target is -13.19% below the current price.
LRN was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LRN.
In the previous month the buy percentage consensus was at a similar level.
LRN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-30 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-01-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-29 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-10-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-11 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-20 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-08 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-08-08 | Canaccord Genuity | Initiate | Buy |
| 2024-07-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-17 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-01-29 | Citigroup | Maintains | Buy -> Buy |
| 2024-01-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-01-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-01-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-12-04 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-11-16 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-11-16 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-10-25 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-10-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |